U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519616) titled 'Effect of Escherichia Coli 5C (Colipral(R)) on Post-Colonoscopy Gastrointestinal Symptoms' on April 02.
Brief Summary: This prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial will evaluate the efficacy and safety of Escherichia coli 5C (Colipral(R)) in adult patients undergoing diagnostic colonoscopy. Participants will be randomized in a 1:1 ratio to receive either Colipral(R) or placebo for 14 days immediately after colonoscopy. The study aims to determine whether Colipral(R) reduces post-colonoscopy gastrointestinal symptoms compared with placebo, using validated symptom and stool assessment too...